// App-Quantinova.ai

BS1 : Reprogramming human macrophages with drug X: potential mechanisms for stabilisation of atherosclerotic plaques

Researchers

Presenter

  • Klaudia Kocsy

Principal Investigators

  • Endre Kiss-Toth

  • Jessica Redgrave

  • Arshad Majid

  • Sheila Francis

Medical Centers

  • Department of Neuroscience, The University of Sheffield, Sheffield, UK

  • Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK

  • CIMA, University of Sheffield, Sheffield, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • Oxidized LDL

  • Cluster of Differentiation 14

  • Interleukin 4

Drug/Treatment

  • IL-4

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A